Population Pharmacology: Precision Dosing for Diverse Patients
*Corresponding Author:Received Date: Jun 22, 2026 / Published Date: Jul 20, 2026
Citation: Moore I (2026) Population Pharmacology: Precision Dosing for Diverse Patients. cpb 15: 588.
Copyright: © 2026 Isabella Moore This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Population pharmacology is critical for understanding drug response variability across diverse patient groups using statistical models. It refines dosing strategies and improves therapeutic efficacy. Integration with pharmacogenomics enhances prediction of individual responses and minimizes adverse reactions. Advanced techniques like machine learning offer deeper insights into drug disposition. Biomarker-guided monitoring optimizes treatment personalization. Novel drug delivery systems are characterized by population modeling. Translational medicine benefits from this approach to bridge preclinical and clinical applications. Real-world data provides broader insights into drug behavior. Organ dysfunction impacts are modeled for dose adjustments. Pediatric population pharmacology ensures safe dosing for children. In oncology, it optimizes treatment by addressing inter-patient variability
